162 related articles for article (PubMed ID: 4888933)
1. Cells, vaccines, and the pursuit of precedent.
Hilleman MR
Natl Cancer Inst Monogr; 1968 Dec; 29():463-9. PubMed ID: 4888933
[No Abstract] [Full Text] [Related]
2. Latent viral infections in donor tissues and in recipients of vaccines.
Melnick JL
Natl Cancer Inst Monogr; 1968 Dec; 29():337-49. PubMed ID: 4305432
[No Abstract] [Full Text] [Related]
3. Clinical experience with vaccines produced in the human diploid cell line WI-38.
Andzaparidze OG
Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
[No Abstract] [Full Text] [Related]
4. Vaccines produced in heteroploid cell lines--discussion.
Hull RN
Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
[No Abstract] [Full Text] [Related]
5. Continuously propagated cell lines. Biochemical identification standards--discussion.
Peterson WD
Natl Cancer Inst Monogr; 1968 Dec; 29():55-7. PubMed ID: 5720808
[No Abstract] [Full Text] [Related]
6. Viral oncogenicity and viral vaccines--general comments.
Gerber P
Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932
[No Abstract] [Full Text] [Related]
7. Tissue and medium antigens in vaccines.
Coriell LL
Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862
[No Abstract] [Full Text] [Related]
8. Vaccines produced in diploid cell lines--discussion.
Perkins FT
Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803
[No Abstract] [Full Text] [Related]
9. Experience with an established cell line for veterinary vaccine production.
Brown AL
Natl Cancer Inst Monogr; 1968 Dec; 29():523-6. PubMed ID: 4305440
[No Abstract] [Full Text] [Related]
10. Technology of production of primary and diploid cell cultures.
Brackett RG
Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
[No Abstract] [Full Text] [Related]
11. Cell substrates for human virus vaccine preparation--general comments.
Hayflick L
Natl Cancer Inst Monogr; 1968 Dec; 29():83-91. PubMed ID: 5720814
[No Abstract] [Full Text] [Related]
12. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Jensen KE
Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793
[No Abstract] [Full Text] [Related]
13. Cell cultures for virus vaccine production. General conclusions from the conference.
Merchant DJ
Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
[No Abstract] [Full Text] [Related]
14. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Fellowes ON
Natl Cancer Inst Monogr; 1968 Dec; 29():209-14. PubMed ID: 5720794
[No Abstract] [Full Text] [Related]
15. Comments on technology of production--continuous cell lines.
Daniels WF
Natl Cancer Inst Monogr; 1968 Dec; 29():71-2. PubMed ID: 5720813
[No Abstract] [Full Text] [Related]
16. Evidence for oncogenic properties of heteroploid cell lines--discussion.
Moore AE
Natl Cancer Inst Monogr; 1968 Dec; 29():291-2. PubMed ID: 4890060
[No Abstract] [Full Text] [Related]
17. Large-scale production of indefinitely propagated cell lines.
Cooper PD
Natl Cancer Inst Monogr; 1968 Dec; 29():63-7. PubMed ID: 5720812
[No Abstract] [Full Text] [Related]
18. Characteristics of primary cultures and diploid cells--technology of production.
Holper JC
Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359
[No Abstract] [Full Text] [Related]
19. Industrial production of primary tissue culture.
Warren J
Natl Cancer Inst Monogr; 1968 Dec; 29():35-43. PubMed ID: 4976363
[No Abstract] [Full Text] [Related]
20. Detection of latent viruses in kidney tissues.
Hsiung GD
Natl Cancer Inst Monogr; 1968 Dec; 29():351-3. PubMed ID: 4305433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
